... Sabourin; Charles Dariane; Jerome Rizk; Francois-Xavier Madec; Francois-Xavier Nouhaud; Xavier Rod; Gaelle Fiard; Benjamin Pradere; Benoit Peyronnet; TRAUMAFUF Collaborative Introduction: The aim of the study was to report the 30-day mortality (30DM) after renal trauma and identify the risk factors...

...Fernando Korkes; Frederico Timoteo; Willy Baccaglini; Felipe Glina; Oscar Rodriguez Faba; Juan Palou Redorta; Sidney Glina Introduction: Mortality after radical cystectomy (RC) varies widely in the literature. In cohort studies, mortality rates can vary from as low as 0.5% in large-volume academic...

...Michael Froehner; Rainer Koch; Samaneh Farahzadi; Ulrike Heberling; Angelika Borkowetz; Lars Twelker; Gustavo B. Baretton; Manfred P. Wirth; Christian Thomas Background: The aim of this study was to determine prognostic factors and to provide long-term mortality data in patients with positive lymph...

...Amandeep Arora; Sameer Rege; Shrinivas Surpam; Kalyansing Gothwal; Anurag Narwade Objective: To identify factors that dictate morbidity and mortality in patients with Fournier’s Gangrene and validate the Fournier gangrene severity index (FGSI). Materials and Methods: We prospectively studied 50...

..., especially in patients with retinoblastoma. For the whole sample, we determined 5- and 10-year cancer-specific cumulative mortality rates of 38 and 50%. Patients with high-grade sarcomas had a trend toward a higher mortality compared with low-grade tumors (p = 0.0280). The most promising treatment option...

...Carolina D'Elia; Evi Comploj; Maria Angela Cerruto; Emanuela Trenti; Salvatore Mario Palermo; Roberto Melotti; Walter Artibani; Armin Pycha Objectives: To identify preoperative risk factors for 90-day mortality and to validate existing nomograms in a multicenter series of patients undergoing...

... Mortality Survival In most cancers, female gender offers a survival advantage; however, this does not appear to extend to bladder cancer [ 1 ]. This is not a newly recognized phenomenon. Yet, despite this, there still exists a gender disparity in cancer-specific mortality [ 2 ]. The cause...

...Mathew D. Sorensen; John N. Krieger Purpose: Case series reported 20-40% mortality rates for patients with Fournier's gangrene with some series as high as 88%. This literature comes almost exclusively from referral centers. Materials and Methods: We identified and analyzed inpatients...

... survival and cancer-specific mortality were compared in 2 different therapy options groups (group of patients who received adjuvant BCG instillation vs. the group of patients who did not receive BCG therapy). Overall mortality was estimated by the Kaplan-Meier method, univariate comparisons were made...

...Andreas Stang; Freddie Bray; Klaus-Peter Dieckmann; Joannie Lortet-Tieulent; Carsten Rusner Background: The decline of testicular cancer mortality in East Germany began in the 1980s, about 10 years later than that recorded in West Germany. We aimed at providing up-to-date time trends of testicular...

... for urinary diversion (25.0%) (p = 0.003). Severe (Clavien grade III-V) medical (3.9 vs. 10.3%) and surgical (2.1 vs. 14.1%) complications were all less frequent in the UC group. Inpatient, 30- and 90-day mortality was 5.8, 7.7 and 17.3% in the UC group as compared to 3.9, 5.9 and 6.9% in the bowel cohort...

...Silvio Altarac; Davorin Katušin; Suad Crnica; Dino Papeš; Zoran Rajković; Nuhi Arslani Introduction: Fournier’s gangrene (FG) is the necrotizing fasciitis of the perineum and genital area with high mortality. Materials and Methods: A retrospective review included 41 patients diagnosed with FG...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Germ cell testicular tumours Mortality...

...D. Jacqmin; A. Nardi; C. Schumacher; C. Bollack Radical cystectomy for bladder cancer is an operation that presents a low mortality rate, which can still be reduced by a better patient selection, particularly with respect to patients presenting a high cardiac risk. Morbidity is still elevated...